The Center for Cancer and Blood Disorders

Fort Worth, Texas 76104

Use our guide to learn which trials are right for you!

We've found
13 trials
at this facility
Metastatic Breast Cancer Clinical Trial
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Enrolling, Phase II
Updated: 3/6/2018
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling, Phase II, III
Updated: 11/22/2016
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Gastroesophageal Cancer Clinical Trial
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Status: Enrolling, Phase II
Updated: 12/14/2017
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects
Status: Enrolling
Updated: 9/21/2017
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Status: Enrolling, Phase II
Updated: 4/18/2017
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
The XENERA™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials